Pharmaceutical Preparations — Ranked by Net Income
SIC 2834 · Annual figures from SEC 10-K filings
These rankings show the largest Pharmaceutical Preparations companies by net income, based on the most recent fiscal year data reported in their annual 10-K filings with the SEC. Only companies with XBRL-tagged financial data are included. Use the tabs below to switch between revenue, net income, and total assets.
| # | Company | Net Income | Fiscal Year |
|---|---|---|---|
| 1 | JOHNSON & JOHNSON JNJ | $26.80B | FY2025 |
| 2 | ELI LILLY & Co LLY | $20.64B | FY2025 |
| 3 | Merck & Co., Inc. MRK | $18.25B | FY2025 |
| 4 | PFIZER INC PFE | $7.77B | FY2025 |
| 5 | BRISTOL MYERS SQUIBB CO CELG-RI | $7.05B | FY2025 |
| 6 | ABBOTT LABORATORIES ABT | $6.52B | FY2025 |
| 7 | REGENERON PHARMACEUTICALS, INC. REGN | $4.50B | FY2025 |
| 8 | VERTEX PHARMACEUTICALS INC / MA VRTX | $3.95B | FY2025 |
| 9 | Zoetis Inc. ZTS | $2.67B | FY2025 |
| 10 | AbbVie Inc. ABBV | $1.82B | FY2025 |
| 11 | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVJF | $1.41B | FY2025 |
| 12 | UNITED THERAPEUTICS Corp UTHR | $1.33B | FY2025 |
| 13 | Royalty Pharma plc RPRX | $770.95M | FY2025 |
| 14 | PTC THERAPEUTICS, INC. PTCT | $682.64M | FY2025 |
| 15 | TG THERAPEUTICS, INC. TGTX | $447.18M | FY2025 |
| 16 | ACADIA PHARMACEUTICALS INC ACAD | $391.00M | FY2025 |
| 17 | RIGEL PHARMACEUTICALS INC RIGL | $367.02M | FY2025 |
| 18 | BIOMARIN PHARMACEUTICAL INC BMRN | $348.90M | FY2025 |
| 19 | ALNYLAM PHARMACEUTICALS, INC. ALNY | $313.75M | FY2025 |
| 20 | BeOne Medicines Ltd. BEIGF | $286.93M | FY2025 |
| 21 | Oncotelic Therapeutics, Inc. OTLC | $249.28M | FY2025 |
| 22 | Alkermes plc. ALKS | $241.66M | FY2025 |
| 23 | Prestige Consumer Healthcare Inc. PBH | $214.61M | FY2025 |
| 24 | CATALYST PHARMACEUTICALS, INC. CPRX | $214.33M | FY2025 |
| 25 | Aurinia Pharmaceuticals Inc. AUPH | $210.79M | FY2025 |
| 26 | Indivior Pharmaceuticals, Inc. INDV | $210.00M | FY2025 |
| 27 | Organon & Co. OGN | $187.00M | FY2025 |
| 28 | KYNTRA BIO, INC. KYNB | $183.45M | FY2025 |
| 29 | CorMedix Inc. CRMD | $163.06M | FY2025 |
| 30 | Harmony Biosciences Holdings, Inc. HRMY | $158.69M | FY2025 |
| 31 | Bausch Health Companies Inc. BHC | $157.00M | FY2025 |
| 32 | Galera Therapeutics, Inc. GRTX | $149.05M | FY2025 |
| 33 | LIGAND PHARMACEUTICALS INC LGNZZ | $124.45M | FY2025 |
| 34 | CORCEPT THERAPEUTICS INC CORT | $99.65M | FY2025 |
| 35 | Amphastar Pharmaceuticals, Inc. AMPH | $98.09M | FY2025 |
| 36 | Keros Therapeutics, Inc. KROS | $87.01M | FY2025 |
| 37 | ZEVRA THERAPEUTICS, INC. ZVRA | $83.23M | FY2025 |
| 38 | ANI PHARMACEUTICALS INC ANIP | $78.34M | FY2025 |
| 39 | Cryoport, Inc. CYRX | $78.30M | FY2025 |
| 40 | Amneal Pharmaceuticals, Inc. AMRX | $72.06M | FY2025 |
| 41 | ABEONA THERAPEUTICS INC. ABEO | $71.18M | FY2025 |
| 42 | ORAMED PHARMACEUTICALS INC. ORMP | $64.05M | FY2025 |
| 43 | Theravance Biopharma, Inc. TBPH | $61.02M | FY2025 |
| 44 | Kiniksa Pharmaceuticals International, plc KNSA | $59.01M | FY2025 |
| 45 | Emergent BioSolutions Inc. EBS | $52.60M | FY2025 |
| 46 | PHIBRO ANIMAL HEALTH CORP PAHC | $48.26M | FY2025 |
| 47 | Organogenesis Holdings Inc. ORGO | $37.03M | FY2025 |
| 48 | XOMA Royalty Corp XOMAP | $31.71M | FY2025 |
| 49 | PUMA BIOTECHNOLOGY, INC. PBYI | $31.11M | FY2025 |
| 50 | Q32 Bio Inc. QTTB | $29.82M | FY2025 |